Navigation Links
Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Date:10/25/2007

Primary Analysis of Pivotal Trial to Be Available No Later Than July 2008

SAN DIEGO, Oct. 25 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced that an independent Data Monitoring Board (DMB) was recently convened to assess time to tumor progression (TTP) for patients in the control group of the Company's pivotal Phase 3 clinical trial of FavId(R). The DMB assessment, which was conducted in accordance with the clinical protocol under Favrille's Special Protocol Assessment (SPA) with the Food & Drug Administration (FDA), indicated that the control group behavior is consistent with data reported in the published literature. Based in part on the guidance provided by the DMB, Favrille has determined April 2008 to be the appropriate time for data cutoff of the Phase 3 trial. The Company anticipates that the analysis of the data will be completed and made available no later than July 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)

The Phase 3 trial is a randomized, double-blind, placebo controlled trial of FavId following Rituxan(R) treatment in patients with follicular B-cell non-Hodgkin's lymphoma (NHL). A total of 349 patients were randomly assigned to receive either FavId plus Leukine(R) (sargramostim, GM-CSF) or placebo plus Leukine following a course of Rituxan treatment. The primary endpoint of this trial is TTP.

"As we previously communicated, the rate of progression in our pivotal Phase 3 trial has slowed during the past 12 months," said John P. Longenecker, Ph.D., President and Chief Executive Officer of Favrille. "We believe this is a positive development, and it has shifted our focus for data cutoff and analysis to trial follow-up time as allowed in the protocol rather than the number of patient progressi
'/>"/>

SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
2. Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
5. XTL Provides Update on Phase I Clinical Trial of XTL-2125
6. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
7. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
8. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
9. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
10. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
11. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2013)... HARRISBURG, Pa. , Dec. 19, 2013 /PRNewswire-iReach/ ... Cardiologist and Director of Cardiovascular Research and Education ... Chief of Cardiothoracic Surgery at PinnacleHealth, performed the ... following the device,s FDA approval. The U.S. Food ... use in the United States ...
(Date:12/19/2013)... OAKS, Calif. , Dec. 19, 2013  Amgen (NASDAQ: ... DESCARTES ( D urable E ffect of PC S ... Plac E bo S tudy) study evaluating the long-term ... high cholesterol met its primary endpoint of percent reduction from ... mean percent reduction in LDL-C, or "bad" cholesterol, was consistent ...
(Date:12/19/2013)... /PRNewswire-iReach/ -- Microtrac, the global pioneer of instrumentation and ... Nanotrac Wave Q, a dynamic light scattering particle size ... Q is the latest in a long line of ... Engineered with the end user in mind, the Nanotrac ... enable the operator to quickly and efficiently measure the ...
Breaking Medicine Technology:Harrisburg-based Cardiovascular Institute Performs First MitraClip Procedure in Pennsylvania 2Harrisburg-based Cardiovascular Institute Performs First MitraClip Procedure in Pennsylvania 3Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 2Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 3Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 4Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 5Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 6Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 7Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 8Introducing the Nanotrac Wave Q, a Particle Size Analyzer that Measures with Unsurpassed Accuracy and Repeatability 2Introducing the Nanotrac Wave Q, a Particle Size Analyzer that Measures with Unsurpassed Accuracy and Repeatability 3
(Date:12/20/2013)... Hospital Pepin Heart Institute and Dr. Kiran C. Patel ... old Clearwater man, has been treated as part of ... Diego-based Cytori Therapeutics, derives stem cells from the patient’s ... parts of the heart. The ATHENA trial is a ... disease. Dr. Charles Lambert, Medical Director of Florida ...
(Date:12/20/2013)... York, NY (PRWEB) December 20, 2013 ... by Quest Diagnostics Inc. (“Quest Diagnostics”), the diagnostic ... Laboratory Corporation of America Holdings Inc. (“LabCorp.”), the ... The settlement concerns the whistleblower lawsuit which ... insurance plans for the payment of "kickbacks" for ...
(Date:12/20/2013)... 2013 SmileCare’s dental team and patients ... of sick children this year. They donated almost 200 ... Hospital. , Orthodontist Geoffrey Kopecky, DDS, teamed ... Drive organizers to arrange for eight SmileCare offices in ... to become collection sites for the stuffed animals. Dr. ...
(Date:12/20/2013)... On behalf of Best Drug Rehabilitation , ... Social Services (CCSS) in order to help the organization provide ... this holiday season. , Per Wickstrom made ... which is located at 11850 Woodrow Wilson Street in Detroit. ... of the organization’s incredible volunteers as they prepared and served ...
(Date:12/20/2013)... December 20, 2013 The holidays should be ... sometimes the stress of making everything perfect throws a wrench ... of tips to eliminate some of the stress hosts and ... said enough that planning ahead saves loads of stress for ... up a menu for every meal, including breakfasts, drinks and ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Pepin Heart Institute is First in West & Central Florida to Perform a Groundbreaking Stem Cell Clinical Trial for Heart Failure Patients 2Health News:Florida Hospital Pepin Heart Institute is First in West & Central Florida to Perform a Groundbreaking Stem Cell Clinical Trial for Heart Failure Patients 3Health News:Florida Hospital Pepin Heart Institute is First in West & Central Florida to Perform a Groundbreaking Stem Cell Clinical Trial for Heart Failure Patients 4Health News:Zamansky LLC Comments On the Settlement By Quest Diagnostics And LabCorp. Of America Of The Whistle-Blower Lawsuit 2Health News:SmileCare Team, Patients Donate Almost 200 Teddy Bears to Help Children Smile 2Health News:Donation by Best Drug Rehabilitation’s CEO Per Wickstrom to Help Detroit’s Cass Community Social Services (CCSS) Make the Holidays Brighter for Children 2Health News:King Kullen’s Tips for a Stress-Free Holiday 2Health News:King Kullen’s Tips for a Stress-Free Holiday 3Health News:King Kullen’s Tips for a Stress-Free Holiday 4Health News:King Kullen’s Tips for a Stress-Free Holiday 5
... Institute of Health and Clinical Excellence (Nice) has planned ... from osteoporosis (porous bones) are at higher risk of ... to prevent fragile bones. ,Post menopausal women ... But Nice wants to execute guidelines according to which, ...
... detention centers has been accused of providing inadequate healthcare ... prison watchdog.// ,Chief Inspector of Prisons Anne ... Immigration Removal Centre in Bedfordshire following concerns raised over ... ,Although Owers praised the work of nurses ...
... Salt and Health has been launched today against salt ... a year.// ,194 medical experts in 48 countries have ... dietary salt intake to prevent high blood pressure. ... Organisation summit in Paris to discuss the role of salt ...
... that ragweed or hay fever symptoms could be reduced by ... at Johns Hopkins in Baltimore. ,Dr. Peter Socrates ... Center at the Johns Hopkins University School of Medicine and ... seasons in Baltimore. ,The study was conducted on ...
... treat wet age-related macular degeneration (wet AMD) could also aid ... AMD is the biggest cause of loss of vision in ... people with a specific type of retina degeneration by giving ... published in the New England Journal of Medicine.,The research involved ...
... shops to overcome depression only one actually has any sound ... said that St John's Wort is the only alternative medicine ... including gingko biloba, ginseng, cat's claw, royal jelly and liquid ... drug interactions". ,The experts, Joyce Reed, a senior ...
Cached Medicine News:Health News:Food Makers Pressurized to Reduce Salt 2Health News:DNA vaccine for ragweed allergies 2Health News:Vision restoration with a drug for macular degeneration 2Health News:Unscientific Depression Drugs aplenty in Health Stores 2
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....
Skull Traction Tongs for cervical vertebra extension, adjustable pins, eliminates need for preliminary drilling, large pattern, complete with wrench...
Cushing Flat Drill, only Component Parts and Accessories for HUDSON Cranial Drill. 14 mm...
Medicine Products: